ClearPoint Neuro, Inc. (NASDAQ:CLPT) Stock Holdings Lessened by Legato Capital Management LLC

Legato Capital Management LLC reduced its holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) by 23.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 122,057 shares of the company’s stock after selling 36,911 shares during the quarter. Legato Capital Management LLC’s holdings in ClearPoint Neuro were worth $1,877,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of CLPT. R Squared Ltd bought a new position in shares of ClearPoint Neuro in the 4th quarter worth about $32,000. Barclays PLC lifted its position in shares of ClearPoint Neuro by 24.3% in the 3rd quarter. Barclays PLC now owns 5,674 shares of the company’s stock worth $64,000 after buying an additional 1,109 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of ClearPoint Neuro by 58.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 9,770 shares of the company’s stock worth $110,000 after acquiring an additional 3,612 shares during the period. Verition Fund Management LLC acquired a new stake in shares of ClearPoint Neuro in the 3rd quarter worth about $123,000. Finally, Oppenheimer & Co. Inc. acquired a new stake in shares of ClearPoint Neuro in the 3rd quarter worth about $156,000. 30.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. B. Riley increased their price objective on shares of ClearPoint Neuro from $15.00 to $20.00 and gave the stock a “buy” rating in a report on Tuesday, January 28th. Lake Street Capital increased their price objective on shares of ClearPoint Neuro from $17.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, January 21st.

ClearPoint Neuro Price Performance

ClearPoint Neuro stock opened at $17.75 on Wednesday. The company’s 50-day moving average price is $16.10 and its two-hundred day moving average price is $13.05. ClearPoint Neuro, Inc. has a 52 week low of $5.11 and a 52 week high of $19.22.

About ClearPoint Neuro

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.